Alembic Pharmaceuticals Limited

NSEI:APLLTD Rapport sur les actions

Capitalisation boursière : ₹214.9b

Alembic Pharmaceuticals Dividendes et rachats

Dividende contrôle des critères 3/6

Alembic Pharmaceuticals est une société versant des dividendes avec un rendement actuel de 1.01% qui est bien couvert par les bénéfices.

Informations clés

1.0%

Rendement du dividende

n/a

Rendement des rachats

Rendement total pour l'actionnairen/a
Rendement futur des dividendes1.3%
Croissance des dividendes7.0%
Prochaine date de paiement du dividenden/a
Date ex-dividenden/a
Dividende par action₹11.000
Ratio de distribution35%

Mises à jour récentes sur les dividendes et les rachats

Recent updates

Earnings Miss: Alembic Pharmaceuticals Limited Missed EPS By 5.6% And Analysts Are Revising Their Forecasts

Nov 10
Earnings Miss: Alembic Pharmaceuticals Limited Missed EPS By 5.6% And Analysts Are Revising Their Forecasts

Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price

Sep 25
Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price

Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?

Sep 03
Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?

Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 13
Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher

Jul 20
Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher

Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly

Jun 03
Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly

Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?

May 11
Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?

Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 08
Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%

Jan 21
Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%

Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Jan 05
Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly

Sep 27
Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly

Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly

Jun 09
Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly

A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Apr 13
A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Feb 22
Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate

Jan 04
Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now

Nov 05
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now

Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden

Aug 10
Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden

Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Jul 20
Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Stabilité et croissance des paiements

Récupération des données sur les dividendes

Dividende stable: Les paiements de dividendes de APLLTD ont été volatils au cours des 10 dernières années.

Dividende croissant: Les paiements de dividendes de APLLTD ont augmenté au cours des 10 dernières années.


Rendement des dividendes par rapport au marché

Alembic Pharmaceuticals Rendement des dividendes par rapport au marché
Comment le rendement du dividende de APLLTD se compare-t-il à celui du marché ?
SegmentRendement du dividende
Entreprise (APLLTD)1.0%
25% du marché (IN)0.3%
25% du marché (IN)1.2%
Moyenne du secteur (Pharmaceuticals)0.7%
Analyste prévisionnel (APLLTD) (jusqu'à 3 ans)1.3%

Dividende notable: Le dividende de APLLTD ( 1.01% ) est supérieur à celui des 25 % des payeurs de dividendes les plus faibles du marché Indian ( 0.25% ).

Dividende élevé: Le dividende de APLLTD ( 1.01% ) est faible par rapport aux 25 % des premiers payeurs de dividendes du marché Indian ( 1.15% ).


Bénéfice distribué aux actionnaires

Couverture des revenus: Avec son taux de distribution relativement faible ( 35.1% ), les paiements de dividendes de APLLTD sont bien couverts par les bénéfices.


Paiement en espèces aux actionnaires

Couverture des flux de trésorerie: Avec son cash payout ratio élevé (266.6%), les paiements de dividendes de APLLTD ne sont pas bien couverts par les flux de trésorerie.


Découvrir des entreprises qui versent des dividendes élevés